Drug Biz Worried Over User Fees' Fate Under Sequestration

Law360, New York (September 21, 2012, 6:44 PM EDT) -- Drugmakers expect to pay full U.S. Food and Drug Administration user fees under a sequestered budget, even though the FDA won't be able to use some of those fees, the head of the Pharmaceutical Research and Manufacturers of America said in a speech Thursday.

John Castellani, president and CEO of PhRMA, explained what the industry thinks will happen if the sequestration goes into effect, slicing more than 8 percent from the FDA's budget.

“The fear is twofold,” Castellani said.

First, the FDA's appropriated funds will be...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.